To evaluate the effectiveness of adjunctive therapeutic plasma exchange in patients with refractory adult-onset still's disease and secondary macrophage activation syndrome.
Single-center retrospective analysis of patients treated with TPE.
Assessment of clinical and biochemical parameters pre- and post-treatment.
Focus on outcomes related to refractory symptoms and macrophage activation syndrome.